Archives
-
CD28-ARS2-PKM Axis Enhances CD8+ T Cell Metabolic Flexibilit
2026-05-30
This study reveals how the CD28-ARS2 signaling axis drives alternative splicing of pyruvate kinase to promote PKM2 expression in activated CD8+ T cells, facilitating metabolic flexibility and robust antitumor immunity. The findings highlight a previously unrecognized mechanism linking costimulatory signaling to immune cell metabolic reprogramming, with implications for cancer immunotherapy research.
-
IWP-L6: Porcupine Inhibitor for Precision Wnt Pathway Modula
2026-05-29
IWP-L6 empowers researchers with sub-nanomolar precision to dissect Wnt signaling dynamics in development, metabolism, and regeneration. Explore actionable workflows, troubleshooting strategies, and translational insights inspired by the latest breakthroughs in Wnt-mediated bone formation.
-
Extracellular Vesicle-Mediated Suppression of Hyphal Growth
2026-05-29
This study reveals that high concentrations of Candida albicans extracellular vesicles (EVs) inhibit hyphal development by upregulating the Nrg1 transcriptional repressor. The findings illuminate a self-regulatory mechanism impacting pathogenicity and candidemia, offering new insights for antifungal strategy development.
-
rhBNP Attenuates Renal Ferroptosis via SCLY-Mediated Seleniu
2026-05-28
This study demonstrates that recombinant human brain natriuretic peptide (rhBNP) protects against renal ischemia-reperfusion injury by inhibiting ferroptosis through upregulation of selenocysteine lyase (SCLY) and enhanced selenium recycling. These findings reveal a novel mechanistic target for acute kidney injury intervention and provide a foundation for improved experimental modeling of renal pathophysiology.
-
ACSL1 Drives Ferroptosis Resistance in Ovarian Cancer Sphero
2026-05-28
This study uncovers how ACSL1 promotes platinum resistance in ovarian cancer by enhancing FSP1 N-myristoylation, resulting in increased ferroptosis resistance. The findings clarify a novel lipid metabolism–driven mechanism underlying antioxidant capacity and cell death regulation in the context of cancer therapy.
-
Ferrostatin-1 (Fer-1): Applied Workflows in Ferroptosis Assa
2026-05-27
Ferrostatin-1 (Fer-1) empowers researchers to selectively inhibit ferroptosis with high sensitivity and reproducibility in cancer biology and neurodegenerative disease models. This guide delivers actionable experimental workflows, troubleshooting insights, and evidence-based protocol enhancements to accelerate translational research using APExBIO’s trusted compound.
-
PHF2 Histone Demethylase Regulates Neuroinflammation in Alzh
2026-05-27
This study identifies PHF2 as a central epigenetic regulator of inflammatory gene expression in Alzheimer’s disease (AD). By demonstrating that PHF2 knockdown reduces neuroinflammation and improves cognitive function in a mouse model, the research highlights PHF2 as a promising therapeutic target for AD and other neuroinflammatory disorders.
-
Tofacitinib Citrate (CP-690550): Precision in JAK3 Research
2026-05-26
Tofacitinib citrate (CP-690550 citrate) offers unmatched selectivity for JAK3, enabling nuanced dissection of immune signaling and endothelial inflammation. This guide presents optimized workflows, protocol parameters, and troubleshooting insights for researchers leveraging this compound in immune regulation and inflammatory disease models.
-
Shufeng Xingbi Therapy Modulates Immunity and Microbiota in
2026-05-26
This study demonstrates that Shufeng Xingbi Therapy (SFXBT) restores Th1/Th2 immune balance and beneficially alters intestinal flora in a rat model of allergic rhinitis (AR). The findings highlight SFXBT’s capacity to alleviate nasal inflammation by regulating immune signaling and microbiome composition, offering mechanistic insights relevant to translational immunology.
-
DGLA-Induced Ferroptosis via ACSL4 in Acute Myeloid Leukemia
2026-05-25
This study uncovers how exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight new mechanistic links between fatty acid metabolism and ferroptotic cell death, suggesting novel therapeutic strategies for treatment-resistant AML.
-
Angiotensin 1/2 (1-6): Redefining RAS Research and Viral Pat
2026-05-25
Angiotensin 1/2 (1-6)—the Asp-Arg-Val-Tyr-Ile-His hexapeptide—has emerged as a pivotal tool for dissecting renin-angiotensin system (RAS) signaling. This article synthesizes mechanistic insights and translational opportunities for researchers exploring vascular tone, renal dynamics, and the novel role of angiotensin fragments in viral pathophysiology, with a focus on SARS-CoV-2 spike–AXL binding. Strategic workflow guidance and protocol parameters are provided to accelerate robust, reproducible discoveries using APExBIO’s Angiotensin 1/2 (1-6).
-
TP53-Dependent DHODH Inhibition in Nasopharyngeal Carcinoma
2026-05-24
Dong et al. demonstrate that inhibiting DHODH, a key enzyme in de novo pyrimidine synthesis, impairs nasopharyngeal carcinoma cell growth through TP53-dependent mechanisms. These findings highlight nucleic acid metabolism as a critical vulnerability in NPC and support DHODH inhibition as a promising therapeutic approach.
-
Ferrostatin-1 (Fer-1): Reliable Ferroptosis Inhibition in Ce
2026-05-23
This article addresses practical laboratory challenges in cell viability, cytotoxicity, and ferroptosis assays while highlighting how Ferrostatin-1 (Fer-1), SKU A4371, from APExBIO, offers reproducible, data-backed solutions. Scenario-driven Q&A explores assay design, data interpretation, protocol optimization, and vendor reliability for biomedical researchers.
-
Chloramphenicol in the Era of Plasmid-Mediated Multidrug Res
2026-05-22
Explore how chloramphenicol, a potent bacterial protein synthesis inhibitor, is redefining molecular biology research amidst the rise of plasmid-borne resistance. This article delivers new perspectives on protocol precision, resistance gene dynamics, and advanced assay design.
-
Proteinase K: Mechanistic Mastery for Translational DNA Puri
2026-05-22
This article provides translational researchers with a mechanistic and strategic guide to leveraging Proteinase K, a recombinant broad-spectrum serine protease, for optimal DNA integrity and workflow reproducibility. Integrating findings from recent selectivity studies, competitive benchmarking, and protocol best practices, it demonstrates how APExBIO's Proteinase K (K1037) advances genomic DNA isolation and contaminant removal beyond standard methods.